News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Patient dosing has commenced in the Phase 1 clinical trial of SENTI-202 – Senti Biosciences
Photo taken from Senti Biosciences/LinkedIn
May 15, 2024, 10:13

Patient dosing has commenced in the Phase 1 clinical trial of SENTI-202 – Senti Biosciences

Tim Lu, Co-Founder and CEO at Senti Biosciences, shared the following post by Senti Biosciences on LinkedIn, adding the following:

“It’s been a tremendous effort by everyone at Senti Biosciences to advance our Logic Gate technology via SENTI-202 into Phase 1 clinical trials. We are very excited about the future and thank everyone who has supported us along the way.”

Quoting Senti Biosciences’ post:

“Today we announced that patient dosing has commenced in the Phase 1 clinical trial of SENTI-202, a potential first-in-class Logic Gated off-the-shelf CAR-NK investigational cell therapy for the treatment of relapsed/refractory hematologic malignancies including acute myeloid leukemia (AML). Learn more.”

Source: Tim Lu/LinkedIn and Senti Biosciences/LinkedIn
OncoDaily

Acute Myeloid Leukemia (AML) Biotechnology cancer CAR-NK cell therapy Clinical Development hematologic malignancies innovative treatments Logic Gate technology OncoDaily Oncology Phase 1 clinical trials Research advancements Senti Biosciences SENTI-202 Supportive efforts Tim Lu
Special Coverage
Blog
Nov 13, 2024, 11:56
HER2-Low Status and Its Impact on Outcomes in Early-Stage Triple-Negative Breast Cancer
Blog
Nov 13, 2024, 11:52
Andrew Pannu: Analysis of Big Pharma Therapeutic M&A Deals from 2019 to today
Blog
Nov 13, 2024, 11:48
Indoor cooking with solid fuels can increase lung cancer risk - IASLC
Blog
Nov 13, 2024, 11:44
Registration for the AACR Annual Meeting 2025 is now open
Blog
Nov 13, 2024, 11:39
i4KIDS I i4KIDS-EUROPE - Ship2B Ventures Impact Forum
Blog
Nov 13, 2024, 11:34
Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting
Blog
Nov 13, 2024, 11:30
ABC Global Alliance - Learning more about brain metastases in breast cancer
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women